伴有下尿路症状的多发性硬化症患者的女性性功能障碍:一项意大利病例对照研究。

IF 2.6 3区 医学 Q1 MEDICINE, GENERAL & INTERNAL
Raffaele Balsamo, Felice Crocetto, Biagio Barone, Ferdinando Fusco, Davide Arcaniolo, Elisabetta Costantini, Ester Illiano, Ugo Amicuzi, Marco Torella, Raffaele Ranavolo, Carmelo Quattrone, Marco De Sio, Simone Tammaro
{"title":"伴有下尿路症状的多发性硬化症患者的女性性功能障碍:一项意大利病例对照研究。","authors":"Raffaele Balsamo, Felice Crocetto, Biagio Barone, Ferdinando Fusco, Davide Arcaniolo, Elisabetta Costantini, Ester Illiano, Ugo Amicuzi, Marco Torella, Raffaele Ranavolo, Carmelo Quattrone, Marco De Sio, Simone Tammaro","doi":"10.1093/sexmed/qfae054","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>Multiple sclerosis (MS) is a recurrent, autoimmune, and inflammatory demyelinating chronic disease that typically manifests in young adulthood and exerts adverse effects on sexual functions.</p><p><strong>Aim: </strong>The study evaluated the prevalence of sexual dysfunctions (SDs) and the relationship with neurological disability, depression, and lower urinary tract symptoms (LUTS) in a cohort of MS female patients, comparing these results with those of healthy women.</p><p><strong>Methods: </strong>From January 2023 to January 2024, consecutive premenopausal female patients with MS, were recruited and the examination included urinalysis, ultrasonography and a urodynamic test according to the International Continence Society standard.</p><p><strong>Outcomes: </strong>Descriptive statistics were reported as mean and standard deviation for continuous variables (analyzed by independent samples Mann-Whitney <i>U</i> test and independent samples Kruskal-Wallis test) while categorical variables were reported as frequency and percentage (analyzed by chi-square test with Fisher's exact test).</p><p><strong>Results: </strong>Female Sexual Function Index (FSFI) total score and all FSFI subscales scores were significantly lower in patients with MS vs healthy control subjects (<i>P <</i> .001); FSFI total scores and all FSFI subscale scores were statistically significantly lower in patients with MS with an International Prostate Symptom Score ≥20 (<i>P <</i> .001) and considering a cutoff for Beck Depression Inventory-II score ≥17, depression was present in 61% (n = 47 of 77) of patients with MS and completely absent in the control group.</p><p><strong>Clinical translation: </strong>The knowledge that SDs are a common problem in MS and in other chronic illnesses can alleviate the feeling of stigma and talking openly of sexual problems can be helpful for the patients and so the doctor-patient relationship can be reinforced.</p><p><strong>Strengths and limitations: </strong>The sample was drawn from a single center, and larger multicenter studies that include both genders are needed to obtain strong results.</p><p><strong>Conclusion: </strong>Our findings confirm the idea of a polygenic and multifactorial etiology of female SDs in MS. Therefore, women with MS should be evaluated in terms of SDs during follow-ups.</p>","PeriodicalId":21782,"journal":{"name":"Sexual Medicine","volume":"12 5","pages":"qfae054"},"PeriodicalIF":2.6000,"publicationDate":"2024-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11443015/pdf/","citationCount":"0","resultStr":"{\"title\":\"Female sexual dysfunctions in multiple sclerosis patients with lower urinary tract symptoms: an Italian case-control study.\",\"authors\":\"Raffaele Balsamo, Felice Crocetto, Biagio Barone, Ferdinando Fusco, Davide Arcaniolo, Elisabetta Costantini, Ester Illiano, Ugo Amicuzi, Marco Torella, Raffaele Ranavolo, Carmelo Quattrone, Marco De Sio, Simone Tammaro\",\"doi\":\"10.1093/sexmed/qfae054\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><strong>Background: </strong>Multiple sclerosis (MS) is a recurrent, autoimmune, and inflammatory demyelinating chronic disease that typically manifests in young adulthood and exerts adverse effects on sexual functions.</p><p><strong>Aim: </strong>The study evaluated the prevalence of sexual dysfunctions (SDs) and the relationship with neurological disability, depression, and lower urinary tract symptoms (LUTS) in a cohort of MS female patients, comparing these results with those of healthy women.</p><p><strong>Methods: </strong>From January 2023 to January 2024, consecutive premenopausal female patients with MS, were recruited and the examination included urinalysis, ultrasonography and a urodynamic test according to the International Continence Society standard.</p><p><strong>Outcomes: </strong>Descriptive statistics were reported as mean and standard deviation for continuous variables (analyzed by independent samples Mann-Whitney <i>U</i> test and independent samples Kruskal-Wallis test) while categorical variables were reported as frequency and percentage (analyzed by chi-square test with Fisher's exact test).</p><p><strong>Results: </strong>Female Sexual Function Index (FSFI) total score and all FSFI subscales scores were significantly lower in patients with MS vs healthy control subjects (<i>P <</i> .001); FSFI total scores and all FSFI subscale scores were statistically significantly lower in patients with MS with an International Prostate Symptom Score ≥20 (<i>P <</i> .001) and considering a cutoff for Beck Depression Inventory-II score ≥17, depression was present in 61% (n = 47 of 77) of patients with MS and completely absent in the control group.</p><p><strong>Clinical translation: </strong>The knowledge that SDs are a common problem in MS and in other chronic illnesses can alleviate the feeling of stigma and talking openly of sexual problems can be helpful for the patients and so the doctor-patient relationship can be reinforced.</p><p><strong>Strengths and limitations: </strong>The sample was drawn from a single center, and larger multicenter studies that include both genders are needed to obtain strong results.</p><p><strong>Conclusion: </strong>Our findings confirm the idea of a polygenic and multifactorial etiology of female SDs in MS. Therefore, women with MS should be evaluated in terms of SDs during follow-ups.</p>\",\"PeriodicalId\":21782,\"journal\":{\"name\":\"Sexual Medicine\",\"volume\":\"12 5\",\"pages\":\"qfae054\"},\"PeriodicalIF\":2.6000,\"publicationDate\":\"2024-10-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11443015/pdf/\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Sexual Medicine\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://doi.org/10.1093/sexmed/qfae054\",\"RegionNum\":3,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q1\",\"JCRName\":\"MEDICINE, GENERAL & INTERNAL\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Sexual Medicine","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1093/sexmed/qfae054","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"MEDICINE, GENERAL & INTERNAL","Score":null,"Total":0}
引用次数: 0

摘要

背景:多发性硬化症(MS)是一种复发性、自身免疫性和炎症性脱髓鞘慢性疾病,通常在青壮年时期发病,对性功能有不良影响。目的:该研究评估了多发性硬化症女性患者群中性功能障碍(SDs)的患病率以及与神经残疾、抑郁和下尿路症状(LUTS)的关系,并将这些结果与健康女性进行了比较:从 2023 年 1 月至 2024 年 1 月,连续招募绝经前女性多发性硬化症患者,根据国际尿失禁协会标准进行尿液分析、超声波检查和尿动力学检查:连续变量的描述性统计以均值和标准差表示(通过独立样本 Mann-Whitney U 检验和独立样本 Kruskal-Wallis 检验进行分析),分类变量的描述性统计以频率和百分比表示(通过秩和检验和费舍尔精确检验进行分析):结果:多发性硬化症患者的女性性功能指数(FSFI)总分和所有FSFI分量表得分均明显低于健康对照组(P.001);国际前列腺症状评分≥20分的多发性硬化症患者的FSFI总分和所有FSFI分量表得分均明显低于健康对照组(P.001);考虑到Beck抑郁清单-II评分的临界值≥17分,61%的多发性硬化症患者(77例中有47例)存在抑郁,而对照组完全不存在抑郁:临床应用:了解SD是多发性硬化症和其他慢性疾病的常见问题,可以减轻耻辱感,公开谈论性问题对患者有帮助,从而加强医患关系:优势和局限性:样本来自于一个中心,要想得到可靠的结果,还需要进行更大规模的多中心研究,并将男女患者都包括在内:我们的研究结果证实了多发性硬化症女性 SD 的多基因和多因素病因学观点。结论:我们的研究结果证实了多发性硬化症女性SD的多基因和多因素病因学观点,因此,女性多发性硬化症患者应在随访期间对SD进行评估。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
Female sexual dysfunctions in multiple sclerosis patients with lower urinary tract symptoms: an Italian case-control study.

Background: Multiple sclerosis (MS) is a recurrent, autoimmune, and inflammatory demyelinating chronic disease that typically manifests in young adulthood and exerts adverse effects on sexual functions.

Aim: The study evaluated the prevalence of sexual dysfunctions (SDs) and the relationship with neurological disability, depression, and lower urinary tract symptoms (LUTS) in a cohort of MS female patients, comparing these results with those of healthy women.

Methods: From January 2023 to January 2024, consecutive premenopausal female patients with MS, were recruited and the examination included urinalysis, ultrasonography and a urodynamic test according to the International Continence Society standard.

Outcomes: Descriptive statistics were reported as mean and standard deviation for continuous variables (analyzed by independent samples Mann-Whitney U test and independent samples Kruskal-Wallis test) while categorical variables were reported as frequency and percentage (analyzed by chi-square test with Fisher's exact test).

Results: Female Sexual Function Index (FSFI) total score and all FSFI subscales scores were significantly lower in patients with MS vs healthy control subjects (P < .001); FSFI total scores and all FSFI subscale scores were statistically significantly lower in patients with MS with an International Prostate Symptom Score ≥20 (P < .001) and considering a cutoff for Beck Depression Inventory-II score ≥17, depression was present in 61% (n = 47 of 77) of patients with MS and completely absent in the control group.

Clinical translation: The knowledge that SDs are a common problem in MS and in other chronic illnesses can alleviate the feeling of stigma and talking openly of sexual problems can be helpful for the patients and so the doctor-patient relationship can be reinforced.

Strengths and limitations: The sample was drawn from a single center, and larger multicenter studies that include both genders are needed to obtain strong results.

Conclusion: Our findings confirm the idea of a polygenic and multifactorial etiology of female SDs in MS. Therefore, women with MS should be evaluated in terms of SDs during follow-ups.

求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
Sexual Medicine
Sexual Medicine MEDICINE, GENERAL & INTERNAL-
CiteScore
5.40
自引率
0.00%
发文量
103
审稿时长
22 weeks
期刊介绍: Sexual Medicine is an official publication of the International Society for Sexual Medicine, and serves the field as the peer-reviewed, open access journal for rapid dissemination of multidisciplinary clinical and basic research in all areas of global sexual medicine, and particularly acts as a venue for topics of regional or sub-specialty interest. The journal is focused on issues in clinical medicine and epidemiology but also publishes basic science papers with particular relevance to specific populations. Sexual Medicine offers clinicians and researchers a rapid route to publication and the opportunity to publish in a broadly distributed and highly visible global forum. The journal publishes high quality articles from all over the world and actively seeks submissions from countries with expanding sexual medicine communities. Sexual Medicine relies on the same expert panel of editors and reviewers as The Journal of Sexual Medicine and Sexual Medicine Reviews.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信